top of page
fondo_blue.jpg
Imagen1.png

Shaping the future 
of healthcare

memberOf.png
Imagen3.png

Who we are

We are a boutique venture capital firm whose mission is to drive disruptive biopharmaceutical innovation in highly burdensome diseases with high unmet treatment needs by supporting impact-driven founders with financial, intellectual, and social capital, while striving for strong investor returns.​

We provide startups with the resources needed to tackle the challenges of early-stage drug development leveraging the extensive experience of our founding partners and a network of top-tier advisors.

Investment approach

icon1.png

High Burden Diseases

We focus on conditions with a massive societal impact, high unmet needs, and insufficient funding, thereby maximizing success opportunities for our investors and improving the lives of millions.

2.png

Highly Innovative Technologies

Groundbreaking solutions that push the boundaries of healthcare are at the core of our strategy, utilizing cutting-edge advancements to tackle critical challenges and drive transformative impact.

icon3.png

Right Valuations

We invest in opportunities with well-grounded valuations, ensuring sustainable growth potential. By balancing innovation with realistic market assessments, we optimize returns while minimizing risk for our investors.

icon4.png

Right Timing

Sila B constantly monitors emerging companies and innovations to identify the ideal moment for investment, aligning with market dynamics and maximizing growth potential.

Portfolio

partner.png
partner.png
partner.png
partner.png
partner.png
partner.png
mision.jpg

Our Mission

Drive disruptive healthcare innovation by supporting impact-driven founders with financial, intellectual, and social capital.

Our Vision

Launch 3 institutional-grade microfunds by 2030, to back 60 startups delivering transformative patient impact and strong investor returns.

Values

Impact, Inspiration, Involvement & Integrity.

Imagen1.png

Shaping the future of healthcare

memberOf.png

Subscribe to receive our latest news

Follow Us

  • LinkedIn
  • X
fondo_blue.png

Venture Partners

jordi Vp.png

Jordi Argente – Redwood City, California 

Tech Startup Advisor. Investment Banker.

•President New Market Venture Management. •Finalis broker-dealer representative and fix edit in last line. •Previous: Managing Director, Woodside Capital Partners & many others.

1715927516364_edited.png

José Antonio Torres - CDMX, México

Entrepreneur & Innovator, Technology & Wellbeing.

•Cofounder Habits AI. •Managing Partner Mexico City Renaissance Executive Forums.

CSO Foto_edited.png

Cecilia Steta - CDMX, México

Managing Director & Fintech Entrepreneur, Global Markets & Corporate Finance.

•Co-Founder & CEO of Rondu.app. •Managing Director at VXT Capital. •Consultant at Q&dro Capital.

Advisors and Venture Partners

We have assembled a strong team of advisors and venture partners to guide and enhance our decision-making process.

logo lateral.png
logo lateral.png

About us

At Sila B Health Ventures, we are more than a venture capital firm—we are a mission-driven team dedicated to transforming healthcare and creating lasting impact. ​

With over 60 years of combined expertise and a partnership spanning three decades, our founding partners, Erik Musalem and Javier Coindreau, bring a unique vision shaped by professional excellence and personal experiences.

 

Having lived the profound toll of cardiovascular, metabolic, neurological, and psychiatric conditions in their own lives and families, they are deeply committed to change. ​

Their shared mission is to empower visionary founders who blend innovation with social impact, driving breakthroughs that save and improve lives.

 

For Erik and Javier, this work goes beyond business, it is a calling fueled by empathy, passion, and an unwavering commitment to reshaping healthcare. 

Partners

Berkeley Haas.png
COOP.png
Material change.png
VO Lab.png
indie bio}.png
Nasdaq.png
Ciocca center.png
SBA.png
alchemist.png
MIT technology review.png
life science angels.png
gaingels.png
MASSBIO.png
HALO HEALTH.png
LIFESPAN.IO.png
the new york academy.png
keiretsu.png
1.png

Financial Capital

We offer tailored investments with checks ranging from $100K to $500K, fueling groundbreaking innovations.

2.png

Social Capital

Our extensive network connects founders to key industry players, advisors, and collaborators, unlocking strategic opportunities.

3.png

Intellectual Capital

We provide material assessment support for development, preclinical and clinical stages as well as coaching, AI tools and mentoring where we provide practical guidance to effectively address early stage challenges.

Value Add to Founders

Portfolio.png
  • Linkedin
  • X

Blog

Icono_Hibrido_.png

Team:
Founding Partners

With 30 years of friendship, proven success and senior expertise, we bring complementary skills and shared experience across two of the world's leading life sciences innovation hubs.

Javier Coindreau, MD. |

General Partner Boston Masachussetts

Javier Photo red.jpeg
Erik_Photo.jpeg

Erik Musalem, MBA, PhD. |

Manager Partner Silicon Valley

bottom of page